RCPI joins Coalition Against Sunbeds campaign
“I used sunbeds when I was younger and now I'm paying the price living with stage 4 melanoma.”
The newly launched Coalition Against Sunbeds has called for a total ban on sunbeds, which directly cause 5% of all melanoma skin cancers in Ireland. Sunbeds cause both melanoma and non-melanoma skin cancers.
Banning sunbeds would help to save lives by decreasing risk factors for melanoma and also save the taxpayer an estimated €9.7 million per year in costly treatments, according to the coalition. Sunbed use dramatically increases a person’s risk of developing melanoma. The risk is increased by 75% for people who use sunbeds before the age of 35. The number of people who will be diagnosed with melanoma is set to double by 2045. Approximately 120,000 people in Ireland use sunbeds. 1 in 20 children aged 10-17 have used sunbeds, despite legislation prohibiting their use by young people under 18.
The Coalition Against Sunbeds’ members include the Irish Cancer Society, the Irish Skin Foundation, Melanoma Support Ireland, the Irish Association of Dermatologists, the Irish College of GPs, Breakthrough Cancer Research, the Marie Keating Foundation and others. The Programme for Government committed to exploring the feasibility of a sunbed ban, and the Department of Health’s Sunbed Working Group subsequently recommended such a ban. The Coalition welcomes this recommendation and is calling for a total ban of all sunbeds, including those in a residential setting, not just commercial sunbeds.
Professor Anne-Marie Tobin, Consultant Dermatologist in Tallaght University Hospital, and Fellow of RCPI said: “The link between sunbeds and skin cancer is clear. The WHO categorises sunbeds as a Group 1 carcinogen meaning their cancer risk is in the same category as tobacco and asbestos exposure. “5.4% of melanomas, the most serious and dangerous form of skin cancer, are directly linked to sunbed use.
This means over 70 people are diagnosed with melanoma in Ireland each year due to sunbeds. Depending on the staging of their diagnosis, these cancers could cost the taxpayer up €9.7 million to treat. "The time has come to act and to ban sunbeds. That is why the Coalition Against Sunbeds has launched today and is urgently calling for Government to set out a timeline for when it will introduce a blanket ban.”
Gill Costelloe, patient advocate with Melanoma Support Ireland said: “I used sunbeds when I was younger and now I'm paying the price because I'm living with stage 4 melanoma, which is a terminal cancer. My melanoma was caught early when I had a mole surgically removed but, five years later, it came back without any warning and spread right through my body, nearly killing me. “Thankfully I'm doing a lot better 4 years on, but I will now be on cancer treatment for the rest of my life. Some day that treatment may stop working and I have to live with that at the back of my mind every single day.
“There was very little education when I was younger about the dangers of sunbeds, but we now know that they are very harmful. I fully support the Coalition Against Sunbeds because we know what damage sunbeds do and we simply cannot sit and watch any more people die from using sunbeds. We need to follow suit of the likes of Australia, who have reduced the potential number of melanoma cases and fatalities by banning commercial sunbeds.”
Members of the Coalition Against Sunbeds include:
- Breakthrough Cancer Research
- Irish Association of Dermatologists
- Irish Cancer Society
- Irish College of GPs
- Irish Skin Foundation
- Irish Dermatology Nurses Association
- Marie Keating Foundation
- Melanoma Support Ireland
- National Youth Council of Ireland
- Royal College of Physicians of Ireland (RCPI)
- United Cancer Advocates Network
- Traveller Visibility Group
The EU’s SCHEER report outlined that an estimated 5.4% of melanomas are attributable to sunbed use. 1,463 people were diagnosed with melanoma in Ireland in 2022. We estimate that 79 people (5.4%) were diagnosed with melanoma in 2022 due to sunbed use and that the costs to the State for treating melanoma in that year could range between €337,251 and €9,715,815, depending on stage at diagnosis.
Sunbeds are Class 1 carcinogens, in the same category as asbestos and tobacco.
Sunbed use before the age of 35 increases the risk of developing melanoma.